Salesforce is charging up its Life Sciences Cloud by joining forces with Takeda and deepening ties with Informatica to ...

Those data centers that are equipped to handle AI processing loads are projected to require $5.2 trillion in capital ...

Dan Gandor, an omnichannel ace who has spent his entire career on the client side of the business, has joined Eversana ...

At a recent gathering, experts in the Swiss biotech and pharma sector underscored the power of international alliances.

Takeda is organized around five core businesses: oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for over 80% of revenue. It also has a developing ...

Salesforce (NYSE:CRM), the #1 AI CRM, today announced that Takeda has selected Salesforce Life Sciences Cloud for Customer Engagement to strengthen its involvement with healthcare professionals ...

Detailed price information for Keros Therapeutics Inc (KROS-Q) from The Globe and Mail including charting and trades.

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: United States, Europe, and International ...

Takeda (TSE: 4502/NYSE:TAK ) today announced that the New England Journal of Medicine published data from the Phase 2b ...

Hereditary angioedema (HAE) is a potentially life-threatening genetic disorder characterized by recurrent swelling attacks.

Japanese pharma major Takeda (TYO: 4502) announced that the US Food and Drug Administration (FDA) has accepted for priority ...

The global antisense oligonucleotides market is poised for remarkable growth over the next decade, projected to rise from USD 2,913.5 million in 2023 to USD 5,519.6 million by 2033 moving forward with ...